PRASCO 327 (Phenylephrine and guaifenesin SR 30 mg / 900 mg)
Pill imprint PRASCO 327 has been identified as Phenylephrine and guaifenesin SR 30 mg / 900 mg.
Guaifenesin/phenylephrine is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 30 mg / 900 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for PRASCO 327 (Phenylephrine and guaifenesin SR 30 mg / 900 mg)
More about guaifenesin/phenylephrine
- Guaifenesin/phenylephrine controlled-release tablets
- Guaifenesin/phenylephrine liquid
- Guaifenesin/phenylephrine suspension
- Guaifenesin/phenylephrine sustained-release capsules
- More (2) »
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...